Public Employees Retirement Association of Colorado Reduces Position in Humana Inc. (NYSE:HUM)

Public Employees Retirement Association of Colorado trimmed its position in Humana Inc. (NYSE:HUM) by 6.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,370 shares of the insurance provider’s stock after selling 1,179 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Humana were worth $6,023,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Ceeto Capital Group LLC boosted its position in Humana by 30.6% in the first quarter. Ceeto Capital Group LLC now owns 2,560 shares of the insurance provider’s stock worth $890,000 after purchasing an additional 600 shares during the last quarter. Bellevue Group AG boosted its position in Humana by 34.9% in the first quarter. Bellevue Group AG now owns 135,541 shares of the insurance provider’s stock worth $46,995,000 after purchasing an additional 35,069 shares during the last quarter. Lazard Asset Management LLC boosted its position in Humana by 8.2% in the first quarter. Lazard Asset Management LLC now owns 406,993 shares of the insurance provider’s stock worth $141,110,000 after purchasing an additional 30,778 shares during the last quarter. Canada Pension Plan Investment Board boosted its position in Humana by 28.5% in the first quarter. Canada Pension Plan Investment Board now owns 527,225 shares of the insurance provider’s stock worth $182,799,000 after purchasing an additional 116,925 shares during the last quarter. Finally, Capital International Inc. CA boosted its position in Humana by 24.4% in the first quarter. Capital International Inc. CA now owns 12,809 shares of the insurance provider’s stock worth $4,441,000 after purchasing an additional 2,512 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Trading Up 0.1 %

HUM traded up $0.23 during trading hours on Monday, reaching $392.86. 854,529 shares of the company’s stock traded hands, compared to its average volume of 1,730,861. The firm has a 50-day moving average price of $365.66 and a 200 day moving average price of $347.02. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.54. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $47.34 billion, a PE ratio of 24.39, a PEG ratio of 2.27 and a beta of 0.51.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on HUM shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $360.00 target price on shares of Humana in a research report on Tuesday, July 23rd. Jefferies Financial Group reduced their price objective on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. Morgan Stanley initiated coverage on Humana in a research note on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price objective on the stock. Wells Fargo & Company reduced their price objective on Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Finally, Robert W. Baird initiated coverage on Humana in a research note on Thursday, May 30th. They issued a “neutral” rating and a $374.00 price objective on the stock. Fourteen analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $402.60.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.